(Q62035314)

English

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

clinical trial

Statements

Heads Up (English)
0 references
A Phase 3b Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Study Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
13 December 2018
0 references
23 July 2020
0 references
650
0 references
18 year
0 references
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit